Loomis, Sayles & Company’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-117,411
Closed -$20.5M 792
2013
Q4
$20.5M Buy
117,411
+8,650
+8% +$1.49M 0.06% 346
2013
Q3
$17.5M Sell
108,761
-591
-0.5% -$93.1K 0.06% 378
2013
Q2
$14.5K Buy
+109,352
New +$15.4M 0.05% 394

Other funds holding ELGX

Loomis, Sayles & Company's ELGX Position: Q1 2014 in Review

Loomis, Sayles & Company sold out of Endologix Inc (ELGX) in Q1 2014, closing a stake of 117,411 shares — an estimated $20.5M sold.

Loomis, Sayles & Company first reported a position in ELGX in Q2 2013 and held it in 3 quarters. The position peaked at $20.5M in Q4 2013. 129 funds tracked by Wall St. Rank hold ELGX as of Q1 2014.

  • Loomis, Sayles & Company reported no remaining Endologix Inc position as of Q1 2014 after selling out during the quarter.
  • Loomis, Sayles & Company sold 117,411 Endologix Inc shares in Q1 2014, an estimated $20.5M.
  • Loomis, Sayles & Company first reported a position in Endologix Inc in Q2 2013 and held it in 3 quarters.
  • Loomis, Sayles & Company's Endologix Inc position peaked at $20.5M in Q4 2013.
  • 129 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2014.

Based on Loomis, Sayles & Company's 13F filing for Q1 2014, filed 15 May 2014.